Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.60
+0.08 (0.76%)
At close: Oct 9, 2026, 4:00 PM EDT
10.61
+0.01 (0.09%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Kura Oncology Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Kura Oncology stock has a consensus rating of "Strong Buy" and an average price target of $31.85. The average 1-year stock price forecast is 200.47% higher than the current stock price, while the lowest is $15 (+41.51%) and the highest is $76 (+616.98%).
Price Target: $31.85 (+200.47%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Kura Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Initiates $30 | Buy | Initiates | $30 | +183.02% | Oct 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $31 | Buy | Maintains | $31 | +192.45% | Sep 29, 2026 |
| Lake Street | Lake Street | Buy Reiterates $23 | Buy | Reiterates | $23 | +116.98% | Sep 10, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $12 | Buy | Maintains | $12 | +14.62% | Sep 10, 2026 |
| Barclays | Barclays | Buy Maintains $28 | Buy | Maintains | $28 | +164.15% | Sep 10, 2026 |
Financial Forecast
Revenue This Year
96.13M
from 67.48M
Increased by 42.46%
Revenue Next Year
208.37M
from 96.13M
Increased by 116.75%
EPS This Year
-3.17
from -3.18
EPS Next Year
-2.35
from -3.17
EPS and Forward PE are based on non-GAAP adjusted numbers.